Replies to post #9217 on Synaptogenix Inc (SNPX)

[InTheTrenches]

My concern, if I owned AVXL, would be that this class of drug (S1R) has failed well-controlled large-scale trials in AD.

NTRP's readout in a well-controlled confirmatory trial is in ~5 months. Don't have to sweat for 2 years like AVXL owners will, hoping that their drug doesn't follow the same fate as past drug trials in this class.